SuperworthSTERIS dividend yield STE
Dividends per share over the last twelve months divided by the share price, since 2005.
- Today, Oct 23, 2026
- 1.11%
- 10-year median
- 1.0%
- Against its 10-year history
- 74th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 0.7% to 1.6%
- Peer median
- 0.9%
STERIS pays 1.11% of its share price in dividends over a year, as of Oct 23, 2026.
That is above its ten-year median of 1.0%, higher than on 74% of days in the last ten years.
Over that time it ranged from 0.7% in Apr 2022 to 1.6% in Dec 2016.
The median for 10 healthcare stocks of a similar size is 0.9%.
Dividend yield over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 1.1% | 0.9% | 1.3% |
| 2025 | 0.9% | 0.9% | 1.1% |
| 2024 | 1.0% | 0.9% | 1.1% |
| 2023 | 0.9% | 0.8% | 1.0% |
| 2022 | 1.0% | 0.7% | 1.1% |
| 2021 | 0.7% | 0.7% | 0.9% |
| 2020 | 0.8% | 0.8% | 1.3% |
| 2019 | 0.9% | 0.9% | 1.3% |
| 2018 | 1.2% | 1.1% | 1.4% |
| 2017 | 1.3% | 1.2% | 1.6% |
| 2016 | 1.6% | 1.3% | 1.6% |
| 2015 | 1.3% | 1.3% | 1.5% |
| 2014 | 1.3% | 1.3% | 1.8% |
| 2013 | 1.7% | 1.6% | 2.0% |
| 2012 | 2.1% | 1.9% | 2.3% |
| 2011 | 2.1% | 1.4% | 2.3% |
| 2010 | 1.4% | 1.4% | 9.2% |
| 2009 | 8.6% | 1.0% | 8.7% |
| 2008 | 1.2% | 0.7% | 1.2% |
| 2007 | 0.7% | 0.6% | 0.8% |
Against its peers
Companies in Healthcare nearest STERIS' size, closest first, today.
| Company | Dividend yield |
|---|---|
| STESTERIS | 1.11% |
| INCYIncyte | n/m |
| THCTenet Healthcare | n/m |
| UTHRUnited Therapeutics | n/m |
| LHLabcorp | 0.88% |
| DGXQuest Diagnostics | 1.40% |
| ZBHZimmer Biomet | n/m |
| MEDPMedpace | n/m |
| WSTWest Pharmaceutical Services | 0.22% |
| RVTYRevvity | n/m |
| DXCMDexCom | n/m |
| Peer median | 0.88% |
Where STERIS ranks
What the dividend yield tells you
Yearly dividends per share divided by the share price.
A yield that suddenly looks high often means the price fell because the dividend is at risk.
More on STERIS
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.